Lymphadenopathy secondary prevention: Revision history

10 February 2021

• curprev 17:3117:31, 10 February 2021‎ Delband Yekta Moazami talk contribs‎ 1,343 bytes +251‎ →‎Secondary Prevention
• curprev 17:0017:00, 10 February 2021‎ Delband Yekta Moazami talk contribs‎ 1,092 bytes +12‎ →‎Secondary Prevention
• curprev 16:3816:38, 10 February 2021‎ Delband Yekta Moazami talk contribs‎ 1,080 bytes +4‎ →‎Secondary Prevention
• curprev 16:3716:37, 10 February 2021‎ Delband Yekta Moazami talk contribs‎ 1,076 bytes +16‎ →‎Overview

28 January 2019

• curprev 16:1916:19, 28 January 2019‎ Amandeep Singh talk contribs‎ 1,060 bytes +57‎ →‎Secondary Prevention Tag: Visual edit
• curprev 16:1316:13, 28 January 2019‎ Amandeep Singh talk contribs‎ 1,003 bytes +272‎ No edit summary

• curprev 16:1016:10, 28 January 2019‎ Amandeep Singh talk contribs‎ 731 bytes +731‎ Created page with "__NOTOC__ {{Lymphadenopathy}} {{CMG}}; {{AE}} {{ADS}} ==Overview== Effective measures for the secondary prevention of lymphadenopathy include [strategy 1], [strategy 2], and..."